DEA

COVID-era telehealth prescribing extended again
Axios
Mon, 11/18/24 - 11:15 am
DEA
HHS
telehealth
virtual prescribing
US poised to ease restrictions on marijuana in historic shift, but it’ll remain controlled substance
AP News
Wed, 05/1/24 - 08:59 am
DEA
marijuana
DEA, FDA outline steps to mitigate ADHD drug shortage
The Hill
Tue, 08/1/23 - 10:30 pm
DEA
FDA
ADHD
drug shortages
DEA will delay telemedicine restrictions for buprenorphine, Adderall, and other drugs
Stat
Wed, 05/3/23 - 10:32 pm
DEA
telemedicine
Adderall
buprenorphine
DEA eases production limits for some narcotics amid shortage during pandemic
Beckers Hospital Review
Wed, 04/8/20 - 10:59 am
DEA
narcotics
COVID-19
controlled substances
DEA moves to fight shortages of medicines needed for Covid-19 patients
Stat
Tue, 04/7/20 - 07:17 pm
DEA
drug shortages
COVID-19
Jazz plans early July launch for sleepiness med Sunosi after DEA scheduling
Fierce Pharma
Mon, 06/17/19 - 11:22 pm
Jazz Pharmaceuticals
FDA
Sunosi
DEA
narcolepsy
GW Pharma, armed with best-case DEA decision, charts path to Epidiolex launch
Fierce Pharma
Thu, 09/27/18 - 12:03 pm
GW Pharma
FDA
Epidiolex
epilepsy
DEA
FDA just approved the first prescription drug derived from marijuana: 4 outstanding questions
Medical Marketing and Media
Tue, 06/26/18 - 10:17 pm
FDA
GW Pharma
Epidiolex
epilepsy
CBD
drug pricing
DEA
DEA gives some of Pfizer's injected narcotic allotment to competitors as production issues intensify shortages
Fierce Pharma
Thu, 05/24/18 - 10:36 am
Pfizer
narcotics
DEA
‘We feel like our system was hijacked’: DEA agents say a huge opioid case ended in a whimper
Washington Post, DC
Mon, 12/18/17 - 10:11 am
McKesson
opioids
opioid crisis
DEA
Tom Marino withdraws his name for consideration as drug czar
Stat
Tue, 10/17/17 - 09:49 am
Tom Marino
Donald Trump
opioids
opioid crisis
DEA
Opioid drugmakers may have to slash production under new DEA proposal
BioPharma Dive
Wed, 08/9/17 - 11:20 pm
DEA
opioids
drug manufacturing
painkillers
Mallinckrodt to settle oxycodone diversion case for $35M with Justice Department
Fierce Pharma
Tue, 04/4/17 - 12:24 am
Mallinckrodt
DOJ
oxycodone
DEA
Drug maker loses lawsuit filed to regain ‘lost’ marketing time
Pharmalot
Mon, 10/5/15 - 05:59 pm
Eisai
Fycompa
Belviq
FDA
DEA
market exclusivity
After New Drugs Delayed by DEA, Legislators Seek Overhaul of Drug Scheduling Process
RAPS.org
Tue, 09/23/14 - 10:38 am
DEA
FDA
drug approvals
An Eisai Special? Bill Would Speed DEA Listings for Controlled Substances
WSJ Pharmalot
Mon, 09/22/14 - 12:09 pm
Eisai
DEA
controlled substances
Most Popular News Headlines For Friday/Saturday August 15-16 2014
CP Wire
Mon, 08/18/14 - 11:48 am
Pfizer
FDA
Eisai
Amgen
Gilead
Sovaldi
Roche
DEA
Repligen
drug manufacturing
Most popular news headlines for Friday/Saturday August 15-16 2014
Mon, 08/18/14 - 11:47 am
Pfizer
FDA
Eisai
Amgen
Gilead
Sovaldi
Roche
DEA
Repligen
drug manufacturing
Eisai Loses Lawsuit Against DEA Over Scheduling Epilepsy Pill
Pharmalot
Fri, 10/25/13 - 09:55 am
Eisai
DEA
epilepsy
Fycompa

Pages